|
DIRC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.745200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.296000E-02 |
| Normal-vs-Stage2 |
5.253800E-01 |
| Normal-vs-Stage3 |
4.157600E-01 |
| Normal-vs-Stage4 |
7.327000E-01 |
| Stage1-vs-Stage2 |
9.196300E-02 |
| Stage1-vs-Stage3 |
8.217000E-01 |
| Stage1-vs-Stage4 |
9.391800E-01 |
| Stage2-vs-Stage3 |
2.563800E-01 |
| Stage2-vs-Stage4 |
6.138200E-01 |
| Stage3-vs-Stage4 |
8.996200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.949400E-01 |
| Normal-vs-AfricanAmerican |
6.841400E-01 |
| Normal-vs-Asian |
5.104400E-01 |
| Caucasian-vs-AfricanAmerican |
8.796400E-01 |
| Caucasian-vs-Asian |
6.085600E-01 |
| AfricanAmerican-vs-Asian |
5.220200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.335700E-02 |
| Normal-vs-Female |
8.598300E-02 |
| Male-vs-Female |
2.117900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.674600E-01 |
| Normal-vs-Extreme_Weight |
3.550200E-02 |
| Normal-vs-Obese |
4.097200E-01 |
| Normal-vs-Extreme_Obese |
5.560000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.322400E-01 |
| Normal_Weight-vs-Obese |
8.245400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.639600E-01 |
| Extreme_Weight-vs-Obese |
2.377600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.676000E-01 |
| Obese-vs-Extreme_Obese |
7.723600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.831200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.823800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.812800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.015780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.040200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.824600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.715000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.917200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.467550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.876800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.659000E-01 |
| Normal-VS-Type2 PRCC |
2.820400E-02 |
| Normal-VS-KIRP CIMP |
2.800000E-01 |
| Normal-VS-Unclassified PRCC |
6.503800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.980400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.609800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.640000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.552160E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.732200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.377400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.993900E-02 |
| Normal-vs-N1 |
5.187600E-01 |
| Normal-vs-N2 |
7.499600E-01 |
| N0-vs-N1 |
5.969200E-01 |
| N0-vs-N2 |
6.583600E-01 |
| N1-vs-N2 |
6.992600E-01 |
|
|
